大数跨境

文献速递丨SCI 高分文献(IF值:5.5)基于免疫调控明胶纳米颗粒的多功能平台:黑色素瘤免疫联合化疗新策略

文献速递丨SCI 高分文献(IF值:5.5)基于免疫调控明胶纳米颗粒的多功能平台:黑色素瘤免疫联合化疗新策略 金源康生物
2026-03-12
2

高分文献速递


客户单位:中国科学技术大学应用化学与工程学院(长春应化所)


期刊:Biomacromolecules


影响因子(IF):5.5

文章题目:

Multifunctional Nanoplatform Based on Gelatin Nanoparticles with Immunomodulatory Capabilities for Combined Immunotherapy and Chemotherapy of Melanoma

文章摘要:

Tumor immunotherapy has shown considerable therapeutic potential, especially when combined with chemotherapy. In this study, we developed a multifunctional nanoplatform GNPs-DOX/R848 that combined immunotherapy and chemotherapy for the treatment of melanoma, in which gelatin nanoparticles (GNPs) were loaded with the immunomodulatory agent resiquimod (R848) and the chemotherapy drug doxorubicin (DOX). GNPs possessed inherent immunomodulatory properties; when combined with R848, they induced a more pronounced polarization of M1-like macrophages by activating the NF-κB signaling pathway, thereby reversing the immunosuppressive tumor microenvironment. Meanwhile, GNPs effectively delivered R848 and DOX to tumor cells, promoting stronger therapeutic effects of the drugs, which strongly induced the immunogenic cell death triggered by DOX, leading to the infiltration of T cells into the tumor tissue. The treatment of melanoma demonstrated that GNPs-DOX/R848 significantly reduced tumor volume, enhanced the therapeutic effects of chemotherapy, providing a new approach for the combined treatment of cancer with immunotherapy and chemotherapy.

原文链接:

https://pubs.acs.org/doi/10.1021/acs.biomac.5c00098

引用产品及培养细胞:FBS-303 RAW264.7 cells

图片
图片

【声明】内容源于网络
0
0
金源康生物
金源康生物是一家专注动物血清、培养基、疫苗佐剂、细胞库及周边产品等研发与生产应用的国家级高新技术企业,奥普赛生物为金源康所属子品牌。咨询热线:400-880-5811,官方网址:www.nmjyk.com
内容 127
粉丝 0
金源康生物 金源康生物是一家专注动物血清、培养基、疫苗佐剂、细胞库及周边产品等研发与生产应用的国家级高新技术企业,奥普赛生物为金源康所属子品牌。咨询热线:400-880-5811,官方网址:www.nmjyk.com
总阅读94
粉丝0
内容127